BioCentury | Apr 22, 2020
Finance

April 21 Financial Quick Takes: ORIC’s IPO plans; plus venture rounds for Magpie, Cloudbreak, ReAlta, New Horizon, Zikani

...from Advent Life Sciences, Gurnet Point Capital and Roche Venture Fund. Zikani, formerly known as Macrolide Pharmaceuticals Inc....
BioCentury | Sep 26, 2019
Company News

Omega: Flagship’s latest venture into the chromatin white space

...in the facility,” Omega CSO Thomas McCauley told BioCentury. McCauley's previous positions include CSO of Macrolide Pharmaceuticals Inc....
BioCentury | Sep 12, 2018
Preclinical News

Genentech develops antibiotic against multidrug resistant Gram-negatives

...and develop antibiotics using Warp Drive's Genome Mining Platform. In April, Roche Ventures invested in Macrolide Pharmaceuticals Inc....
BioCentury | Sep 5, 2018
Company News

Management tracks: Agios, Radius

...and CFO of CRISPR-associated protein 9 (Cas9) company Intellia Therapeutics Inc. (NASDAQ:NTLA). Infectious disease company Macrolide Pharmaceuticals Inc....
BioCentury | Apr 6, 2018
Financial News

Macrolide raises $20M

...A round in 2015. Macrolide Pharmaceuticals Inc., Watertown, Mass. Mary Romeo Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator Harvard University Intarcia Therapeutics Inc. Macrolide Pharmaceuticals Inc....
BioCentury | Apr 2, 2018
Financial News

Antibiotic play Macrolide raises $20M, names Karande CEO

...now CEO of Apnimed Inc. (Cambridge, Mass.). Mary Romeo Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator Harvard University Intarcia Therapeutics Inc. Macrolide Pharmaceuticals Inc....
BioCentury | Jun 9, 2016
Tools & Techniques

Building a better haystack

...Selina Koch, Staff Writer A year after raising $22 million in a series A round, Macrolide Pharmaceuticals Inc....
...said. Companies and Institutions Mentioned Cempra Inc. (NASDAQ:CEMP), Chapel Hill, N.C. Harvard University, Cambridge, Mass. Macrolide Pharmaceuticals Inc....
...ring (not shown). Adapted with permission from Macrolide Pharmaceuticals Inc. From red to green Compounds generated by Macrolide Pharmaceuticals Inc....
BioCentury | Jun 2, 2016
Distillery Techniques

Techniques: Chemical synthesis platform to create structurally diverse libraries of macrolide antibiotics

...synthesis platform to create structurally diverse libraries of macrolide antibiotics LICENSING STATUS: Patented; licensed to Macrolide Pharmaceuticals Inc....
BioCentury | Jun 29, 2015
Finance

Viehbacher navigates to Waypoint

...fund's first investment was a $22 million series A round in March for antibiotics play Macrolide Pharmaceuticals Inc....
BioCentury | Apr 13, 2015
Emerging Company Profile

Building macrolides

...N.C. Harvard University, Cambridge, Mass. Macrolide Pharmaceuticals Inc., Newton, Mass. Tetraphase Pharmaceuticals Inc. (NASDAQ:TTPH), Watertown, Mass. Sidebars Macrolide Pharmaceuticals Inc....
Items per page:
1 - 10 of 11
BioCentury | Apr 22, 2020
Finance

April 21 Financial Quick Takes: ORIC’s IPO plans; plus venture rounds for Magpie, Cloudbreak, ReAlta, New Horizon, Zikani

...from Advent Life Sciences, Gurnet Point Capital and Roche Venture Fund. Zikani, formerly known as Macrolide Pharmaceuticals Inc....
BioCentury | Sep 26, 2019
Company News

Omega: Flagship’s latest venture into the chromatin white space

...in the facility,” Omega CSO Thomas McCauley told BioCentury. McCauley's previous positions include CSO of Macrolide Pharmaceuticals Inc....
BioCentury | Sep 12, 2018
Preclinical News

Genentech develops antibiotic against multidrug resistant Gram-negatives

...and develop antibiotics using Warp Drive's Genome Mining Platform. In April, Roche Ventures invested in Macrolide Pharmaceuticals Inc....
BioCentury | Sep 5, 2018
Company News

Management tracks: Agios, Radius

...and CFO of CRISPR-associated protein 9 (Cas9) company Intellia Therapeutics Inc. (NASDAQ:NTLA). Infectious disease company Macrolide Pharmaceuticals Inc....
BioCentury | Apr 6, 2018
Financial News

Macrolide raises $20M

...A round in 2015. Macrolide Pharmaceuticals Inc., Watertown, Mass. Mary Romeo Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator Harvard University Intarcia Therapeutics Inc. Macrolide Pharmaceuticals Inc....
BioCentury | Apr 2, 2018
Financial News

Antibiotic play Macrolide raises $20M, names Karande CEO

...now CEO of Apnimed Inc. (Cambridge, Mass.). Mary Romeo Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator Harvard University Intarcia Therapeutics Inc. Macrolide Pharmaceuticals Inc....
BioCentury | Jun 9, 2016
Tools & Techniques

Building a better haystack

...Selina Koch, Staff Writer A year after raising $22 million in a series A round, Macrolide Pharmaceuticals Inc....
...said. Companies and Institutions Mentioned Cempra Inc. (NASDAQ:CEMP), Chapel Hill, N.C. Harvard University, Cambridge, Mass. Macrolide Pharmaceuticals Inc....
...ring (not shown). Adapted with permission from Macrolide Pharmaceuticals Inc. From red to green Compounds generated by Macrolide Pharmaceuticals Inc....
BioCentury | Jun 2, 2016
Distillery Techniques

Techniques: Chemical synthesis platform to create structurally diverse libraries of macrolide antibiotics

...synthesis platform to create structurally diverse libraries of macrolide antibiotics LICENSING STATUS: Patented; licensed to Macrolide Pharmaceuticals Inc....
BioCentury | Jun 29, 2015
Finance

Viehbacher navigates to Waypoint

...fund's first investment was a $22 million series A round in March for antibiotics play Macrolide Pharmaceuticals Inc....
BioCentury | Apr 13, 2015
Emerging Company Profile

Building macrolides

...N.C. Harvard University, Cambridge, Mass. Macrolide Pharmaceuticals Inc., Newton, Mass. Tetraphase Pharmaceuticals Inc. (NASDAQ:TTPH), Watertown, Mass. Sidebars Macrolide Pharmaceuticals Inc....
Items per page:
1 - 10 of 11